Form 4: AbbVie Executive Azita Saleki-Gerhardt Reports Disposition of Shares
SEC Form 4 Filing
EVP, Chief Operations Officer of AbbVie, Azita Saleki-Gerhardt, reports the disposition of 25,630 shares of common stock on September 24, 2024.
Summary
- Azita Saleki-Gerhardt, EVP, Chief Operations Officer of AbbVie, filed a Form 4 on September 30, 2024.
- The report details a transaction on September 24, 2024, where she disposed of 25,630 shares of AbbVie common stock.
- Following the transaction, Saleki-Gerhardt directly owns 194,348 shares.
- She also indirectly owns 2,322 shares through a profit-sharing trust and 3,873 shares held by her spouse, for which she disclaims beneficial ownership.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock transaction. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Industry Context
Executive stock transactions are routinely monitored as they can provide insights into an executive's perspective on the company's performance and future prospects. However, they can also be related to personal financial planning.
Stakeholder Impact
- The transaction could have a minor impact on shareholders if interpreted as a lack of confidence by the executive, although such transactions are common and often part of personal financial planning.
Key Dates
| Date | Description |
|---|---|
| January 31, 2024 | Balance in AbbVie Savings program as of this date. |
| September 24, 2024 | Date of the stock transaction (disposition of shares). |
| September 30, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.